Worldwide urologic guidelines now point to mpMRI prior to every biopsy. This means Radiology's interpretation of mpMRI is critical to the prostate cancer pathway.
Existing nomenclature carries different meanings between Radiology and Urology departments. For example, right-mid medial on a Radiologist's MRI may be dissimilar to right-mid medial on a Urologist's ultrasound image during biopsy.
Tools that ensure accurate communication between Radiology and Urology are critical to enhancing patient outcomes.
1 in 6 lesions
are subject to misinterpretation.1
As a result of differences in patient positioning during MRI acquisition and biopsy, one in six lesions are reported in a different sector than they appear during US-guided biopsy.1 In fact, the average orientation difference between MRI and ultrasound biopsy is 12 degrees.1
MIM Symphony Dx™ allows Radiology findings to be accurately and rapidly translated to the industry-leading Urology ultrasound platform, bkFusion™. MIM and BK enable you to speak the same language as your referring Urologist.
Fill out the form below to begin optimizing your Urology collaboration.
1. J Piper, F Giganti, D Mirando, K Krawiec, AS Nelson, C Allen, MIM Software Inc, University College London Hospital; Evaluation of the impact of orientation differences between mpMRI and US in biopsy. Study presented at the European Society of Urogenital Radiology Association, Barcelona, SP
MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.
Copyright © 2021 MIM Software Inc. All Rights Reserved.